Calcitonin gene-related peptide in myocardial ischaemia and reperfusion in the pig

被引:44
作者
Källner, G [1 ]
Gonon, A
Franco-Cereceda, A
机构
[1] Karolinska Hosp, Dept Thorac Surg, S-17176 Stockholm, Sweden
[2] Karolinska Hosp, Dept Cardiol, S-17176 Stockholm, Sweden
关键词
C fiber; CGRP; CGRP(8-37); ischemia; pig; reperfusion;
D O I
10.1016/S0008-6363(98)00016-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: In myocardial ischaemia, slow conducting capsaicin-sensitive C-fibres are activated. Apart from the mediation of pain, activation of these fibres causes release of various peptides, such as calcitonin gene-related peptide (CGRP), which is a potent vasodilator. The aim of this study was to investigate the role of CGRP in the context of myocardial ischaemia in vivo. Methods: The left anterior descending coronary artery (LAD) was occluded during 45 min in 27 anaesthetised open-chest pigs. LAD flow, mean arterial pressure (MAP), heart rate, peak dP/dt, arterial and coronary venous concentration of CGRP was measured prior to ischaemia, and during 4 h of reperfusion. The extent of myocardial infarction was measured using staining with triphenyl tetrazolium chloride. Results: Retroinfusion of CGRP(100 mu g) into the ischaemic myocardium was associated with a more pronounced hyperaemia, and systemic hypotension, during early reperfusion. The infarct size in relation to the area at risk was not affected by CGRP or the CGRP antagonist CGRP(8-37), and averaged 67 +/- 3%. There were no changes in plasma CGRP levels during ischaemia or reperfusion. Conclusion: Exogenously administered CGRP can cause systemic hypotension and augments postischaemic coronary flow. In this model, no cardioprotective effect of CGRP could be proven. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:493 / 499
页数:7
相关论文
共 31 条
[1]   PROGRESSIVE IMPAIRMENT OF REGIONAL MYOCARDIAL PERFUSION AFTER INITIAL RESTORATION OF POSTISCHEMIC BLOOD-FLOW [J].
AMBROSIO, G ;
WEISMAN, HF ;
MANNISI, JA ;
BECKER, LC .
CIRCULATION, 1989, 80 (06) :1846-1861
[2]  
BEVAN S, 1990, TRENDS PHARMACOL SCI, V11, P330
[3]   IN-VITRO EFFECTS OF CAPSAICIN - ANTIARRHYTHMIC AND ANTIISCHEMIC ACTIVITY [J].
DALONZO, AJ ;
GROVER, GJ ;
DARBENZIO, RB ;
HESS, TA ;
SLEPH, PG ;
DZWONCZYK, S ;
ZHU, JL ;
SEWTER, JC .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 272 (2-3) :269-278
[4]  
ECKSTEIN RW, 1954, CIRC RES, V2, P460
[5]   CALCITONIN GENE-RELATED PEPTIDE - A POTENT MODULATOR OF CORONARY FLOW [J].
EZRA, D ;
LAURINDO, FRM ;
GOLDSTEIN, DS ;
GOLDSTEIN, RE ;
FEUERSTEIN, G .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1987, 137 (01) :101-105
[6]   EARLY PHASE ACUTE MYOCARDIAL INFARCT SIZE QUANTIFICATION - VALIDATION OF THE TRIPHENYL TETRAZOLIUM CHLORIDE TISSUE ENZYME STAINING TECHNIQUE [J].
FISHBEIN, MC ;
MEERBAUM, S ;
RIT, J ;
LANDO, U ;
KANMATSUSE, K ;
MERCIER, JC ;
CORDAY, E ;
GANZ, W .
AMERICAN HEART JOURNAL, 1981, 101 (05) :593-600
[7]  
FRANCOCERECEDA A, 1988, ACTA PHYSIOL SCAND, V133, P1
[8]   RESINIFERATOXIN-EVOKED, CAPSAICIN-EVOKED AND CGRP-EVOKED PORCINE CORONARY VASODILATATION IS INDEPENDENT OF EDRF MECHANISMS BUT ANTAGONIZED BY CGRP (8-37) [J].
FRANCOCERECEDA, A .
ACTA PHYSIOLOGICA SCANDINAVICA, 1991, 143 (03) :331-337
[9]   CAPSAZEPINE-SENSITIVE RELEASE OF CALCITONIN-GENE-RELATED PEPTIDE FROM C-FIBER AFFERENTS IN THE GUINEA-PIG HEART BY LOW PH AND LACTIC-ACID [J].
FRANCOCERECEDA, A ;
KALLNER, G ;
LUNDBERG, JM .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 238 (2-3) :311-316
[10]   CALCITONIN GENE-RELATED PEPTIDE BUT NOT SUBSTANCE-P MIMICS CAPSAICIN-INDUCED CORONARY VASODILATION IN THE PIG [J].
FRANCOCERECEDA, A ;
RUDEHILL, A ;
LUNDBERG, JM .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1987, 142 (02) :235-243